Rewiring networks for a pathogenic lifestyle

重新连接网络以适应致病的生活方式

基本信息

  • 批准号:
    10893669
  • 负责人:
  • 金额:
    $ 60.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-01 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary Vibrio cholerae causes the severe diarrheal disease cholera that is endemic in much of Asia, Africa, and South America, and has recently reemerged in Haiti, Syria, and Ukraine. The species is highly diverse, although only O1 or O139 serogroup strains cause epidemic disease. However, increasing sporadic disease has been reported globally, and is caused by strains belonging to non-O1/non-O139 serogroups that present a public health threat both in developed and industrialized nations, including the United States. Unlike pathogenic O1 and O139 strains, the vast majority of pathogenic non-O1/non-O139 strains do not carry the well characterized virulence factors for colonization (TCP) and toxin production (CT), and the virulence mechanisms used by these strains are not well understood. Our study of pathogenic non-O1/non-O139 serogroup strains began with genomic sequencing of the clinically isolated O39 serogroup strain, AM-19226, which revealed a Type Three Secretion System (T3SS) that is conserved among other V. cholerae isolates. Like TCP and CT, the T3SS is acquired by horizontal gene transfer (HGT), and integrated into the ancestral chromosome. Our subsequent experiments identified two membrane localized transcriptional activators (MLTAs) encoded within the T3SS genomic pathogenicity island (PAI), which are essential for T3SS function in vivo and in vitro. We also found that ToxR, an ancestral MLTA required for TCP and CT expression, is important for T3SS regulation. ToxR is encoded by all strains of V. cholerae where it regulates core chromosomal functions, and is well-studied as an MLTA that cross-regulates PAI and ancestral gene expression. Interestingly, we found that the T3SS encoded MLTAs influence ancestral gene expression and phenotypes such as motility and biofilm formation. We hypothesize that in order to survive in aquatic environments and also cause disease, T3SS-positive V. cholerae must integrate virulence gene regulation with transcriptional circuits outside of the PAI, leveraging the activities of both ancestral and newly acquired, PAI encoded transcriptional regulatory factors. We propose to use complementary genetic and biochemical approaches to identify and characterize the mechanisms used by T3SS PAIs to coordinate motility, biofilm formation, and T3SS gene expression in response to environmental cues. Initial studies will define the regulons for T3SS MLTAs, and the conditions promoting regulation. We will investigate protein-protein interactions and MLTA transcriptional domain sequence specificity. Initial studies will focus on VttRA as the protein at the top of the regulatory hierarchy. Our overall goal is to discover how PAI encoded MLTA activity regulates virulence phenotypes and ancestral physiological traits that are necessary to maintain dual lifestyles of newly evolved pathogens.
项目摘要 弧菌霍乱引起严重的腹泻病霍乱,在亚洲,非洲和南部的大部分地区是地方性的 美国,最近在海地,叙利亚和乌克兰重新出现。该物种高度多样 O1或O139血清群菌株引起流行病。但是,偶发性疾病的增加一直是 全球报告,是由属于非O1/non-O139血清群的菌株引起的 包括美国在内的发达国家和工业化国家中的健康威胁。与致病性O1不同 和O139菌株,绝大多数致病性非O1/non-O139菌株都不具有良好的特征 定植(TCP)和毒素产生(CT)的毒力因子以及这些使用的毒力机制 菌株不太了解。我们对致病性非O1/非O139血清群菌株的研究始于 临床分离的O39血清群菌株AM-19226的基因组测序,该菌株揭示了三型 分泌系统(T3SS)在其他V.霍乱分离株中保守。像TCP和CT一样,T3SS是 通过水平基因转移(HGT)获取,并整合到祖先染色体中。我们随后的 实验确定了两个膜局部转录激活剂(MLTA),该激活剂(MLTA)在T3SS中编码 基因组致病岛(PAI),这对于T3SS在体内和体外的功能至关重要。我们还发现 TOXR是TCP和CT表达所需的祖先MLTA,对于T3SS调节很重要。 Toxr是 由霍乱甲状腺菌的所有菌株编码,在该菌株中调节核心染色体功能,并被充分研究为 跨调节PAI和祖先基因表达的MLTA。有趣的是,我们发现T3SS编码 MLTA会影响祖先基因表达和表型,例如运动和生物膜形成。我们 假设为了在水生环境中生存并引起疾病,T3SS阳性V.霍乱 必须将毒力基因调节与PAI之外的转录电路整合,以利用活动 PAI编码的转录调节因素中的祖先和新获得的。我们建议使用 补充遗传和生化方法,以识别和表征T3SS使用的机制 PAIS以响应环境线索来协调运动性,生物膜形成和T3SS基因表达。 初步研究将定义T3SS MLTA的规范,以及促进调节的条件。我们将 研究蛋白质 - 蛋白质相互作用和MLTA转录域序列特异性。最初的研究将 专注于VTTRA作为调节层次结构顶部的蛋白质。我们的总体目标是发现Pai 编码的MLTA活性调节毒力表型和祖先的生理特征是必要的 保持新进化的病原体的双重生活方式。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

MICHELLE DZIEJMAN的其他基金

Novel effector protein functions encoded by T3SS positive V. cholerae
T3SS 阳性霍乱弧菌编码的新效应蛋白功能
  • 批准号:
    10199931
    10199931
  • 财政年份:
    2017
  • 资助金额:
    $ 60.99万
    $ 60.99万
  • 项目类别:
Pathogenic mechanisms of non-01/non-0139 V. cholerae
非01/非0139霍乱弧菌的致病机制
  • 批准号:
    8287501
    8287501
  • 财政年份:
    2008
  • 资助金额:
    $ 60.99万
    $ 60.99万
  • 项目类别:
Pathogenic mechanisms of non-01/non-0139 V. cholerae
非01/非0139霍乱弧菌的致病机制
  • 批准号:
    8067084
    8067084
  • 财政年份:
    2008
  • 资助金额:
    $ 60.99万
    $ 60.99万
  • 项目类别:
Pathogenic mechanisms of non-01/non-0139 V. cholerae
非01/非0139霍乱弧菌的致病机制
  • 批准号:
    7525518
    7525518
  • 财政年份:
    2008
  • 资助金额:
    $ 60.99万
    $ 60.99万
  • 项目类别:
Pathogenic mechanisms of non-01/non-0139 V. cholerae
非01/非0139霍乱弧菌的致病机制
  • 批准号:
    7631195
    7631195
  • 财政年份:
    2008
  • 资助金额:
    $ 60.99万
    $ 60.99万
  • 项目类别:
Pathogenic mechanisms of non-01/non-0139 V. cholerae
非01/非0139霍乱弧菌的致病机制
  • 批准号:
    7848314
    7848314
  • 财政年份:
    2008
  • 资助金额:
    $ 60.99万
    $ 60.99万
  • 项目类别:
MCP-4 AND LEUKOCYTE TRAFFICKING AND ACTIVATION
MCP-4 与白细胞运输和激活
  • 批准号:
    2667662
    2667662
  • 财政年份:
    1998
  • 资助金额:
    $ 60.99万
    $ 60.99万
  • 项目类别:
MCP-4 AND LEUKOCYTE TRAFFICKING AND ACTIVATION
MCP-4 与白细胞运输和激活
  • 批准号:
    2002982
    2002982
  • 财政年份:
    1997
  • 资助金额:
    $ 60.99万
    $ 60.99万
  • 项目类别:

相似国自然基金

非洲猪瘟病毒B475L蛋白靶向LMP2抑制抗原递呈的分子机制
  • 批准号:
    32302894
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
非洲猪瘟病毒pS273R通过切割G3BP1调控宿主应激颗粒形成的机制
  • 批准号:
    32302893
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
抗体依赖性增强效应介导非洲猪瘟病毒致病的分子机制
  • 批准号:
    32373024
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
非洲爪蟾IV型干扰素IFN-upsilon在不同发育阶段的抗病毒功能研究
  • 批准号:
    32303043
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

International Conference on Cancer Health Disparities
国际癌症健康差异会议
  • 批准号:
    10606212
    10606212
  • 财政年份:
    2023
  • 资助金额:
    $ 60.99万
    $ 60.99万
  • 项目类别:
Adapting and Piloting an Evidence-based Intervention to Improve Hypertension Care among Tanzanians Living with HIV
调整和试点循证干预措施以改善坦桑尼亚艾滋病毒感染者的高血压护理
  • 批准号:
    10750666
    10750666
  • 财政年份:
    2023
  • 资助金额:
    $ 60.99万
    $ 60.99万
  • 项目类别:
Annual Retreat of the International Society for Environmental Epidemiology
国际环境流行病学学会年度务虚会
  • 批准号:
    10682974
    10682974
  • 财政年份:
    2023
  • 资助金额:
    $ 60.99万
    $ 60.99万
  • 项目类别:
Evaluation of a Next Generation SchistoShield Vaccine
下一代 SchistoShield 疫苗的评估
  • 批准号:
    10761529
    10761529
  • 财政年份:
    2023
  • 资助金额:
    $ 60.99万
    $ 60.99万
  • 项目类别:
Clinical decision support algorithm to optimize management of respiratory tract infection in children attending primary health facilities in Kilimanjaro Region, Tanzania
用于优化坦桑尼亚乞力马扎罗地区初级卫生机构儿童呼吸道感染管理的临床决策支持算法
  • 批准号:
    10734148
    10734148
  • 财政年份:
    2023
  • 资助金额:
    $ 60.99万
    $ 60.99万
  • 项目类别: